Warning
Precision Dose Inc. Recalls Glycopyrrolate Oral Solution
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0741-2026Drug / Pharmaceutical
Precision Dose Inc. Recalls Glycopyrrolate Oral Solution
Precision Dose Inc. · Class II — Moderate Risk
Product Description
Glycopyrrolate Oral Solution, 1 mg/5 mL, delivers 5 mL, Rx only, Pkg: Precision Dose, Inc, S. Beloil, IL 61080, unit-dose oral syringes, NDCs 68094-073-01 (oral syringe) and 68094-073-58 (case).
Reason for Recall
Failed Impurities/Degradation Specifications
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
US Nationwide.
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
Precision Dose Inc. has recalled a pharmaceutical product that the FDA classified as Class II. The recall was initiated on July 14, 2026. Failed Impurities/Degradation Specifications. It was distributed in US Nationwide. Class II recalls involve products that might cause a temporary health problem or pose only a slight threat of a serious nature. Consumers should discontinue use and contact the firm.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medical Product Contamination.